close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Strona główna・Stock List・Nektar Therapeutics
Search

Nektar Therapeutics

Closed

36.56 4.64

Buy

Price update 6 lut 2026, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

34.5

Max

37.11

Key metrics

By Trading Economics

Income

6.1M

-36M

Sales

615K

12M

EPS

-1.87

Profit margin

-301.289

Employees

61

EBITDA

6.9M

-29M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+195.79% upside

Dividends

By Dow Jones

Next Earnings

11 mar 2026

Market Stats

By TradingEconomics

Market Cap

-364M

775M

Previous open

31.92

Previous close

36.56

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

0.5949 / 0.7406 Support & Resistance

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

6 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

6 lut 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

6 lut 2026, 21:40 UTC

Acquisitions, Mergers, Takeovers

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

DJ

Read

6 lut 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

DJ

Read

6 lut 2026, 21:17 UTC

Earnings

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

DJ

Read

6 lut 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Read

6 lut 2026, 21:14 UTC

Acquisitions, Mergers, Takeovers

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

DJ

Read

6 lut 2026, 21:13 UTC

Earnings

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

DJ

Read

6 lut 2026, 21:13 UTC

Earnings

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

DJ

Read

6 lut 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

DJ

Read

6 lut 2026, 20:34 UTC

Earnings

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

DJ

Read

6 lut 2026, 20:27 UTC

Earnings

These Stocks Are Today's Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More -- Barrons.com

DJ

Read

6 lut 2026, 20:24 UTC

Market Talk

Oil Futures Settle Higher As U.S.-Iran Talks Get Under Way -- Market Talk

DJ

Read

6 lut 2026, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Retreat Ahead of Weekend -- Market Talk

DJ

Read

6 lut 2026, 19:48 UTC

Earnings

Take-Two, Mondelez Get Analyst Attention -- Barrons.com

DJ

Read

6 lut 2026, 19:30 UTC

Acquisitions, Mergers, Takeovers

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- WSJ

DJ

Read

6 lut 2026, 19:30 UTC

Acquisitions, Mergers, Takeovers

Justice Department Asking Industry How Netflix or Paramount Deal for Warner Bros. Might Impact Competition, According to Subpoena -- WSJ

DJ

Read

6 lut 2026, 19:30 UTC

Acquisitions, Mergers, Takeovers

DOJ Asking if Netflix Engaged in 'Exclusionary Conduct' That May Lead to Monopoly, According to Subpoena -- WSJ

DJ

Read

6 lut 2026, 19:17 UTC

Market Talk

USDA Says Farm Income to Decrease in 2026 -- Market Talk

DJ

Read

6 lut 2026, 18:50 UTC

Earnings

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

DJ

Read

6 lut 2026, 18:47 UTC

Market Talk

Natural Gas-Infrastructure Operators Take 'Flight to Scale' -- Market Talk

DJ

Read

6 lut 2026, 18:34 UTC

Market Talk

U.S. Oil Rig Count Rises By 1 to 412 -- Market Talk

DJ

Read

6 lut 2026, 17:58 UTC

Earnings

Reddit Stock Falls After Strong Earnings. Wall Street Is Debating What's Next. -- Barrons.com

DJ

Read

6 lut 2026, 17:52 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

DJ

Read

6 lut 2026, 17:52 UTC

Market Talk
Earnings

Amazon's CapEx Seen as Misunderstood by Investors -- Market Talk

DJ

Read

6 lut 2026, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

6 lut 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

6 lut 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

6 lut 2026, 17:18 UTC

Market Talk

Canada's Bizarre Jobs Report Points to Growing Labor Slack -- Market Talk

DJ

Read

6 lut 2026, 17:09 UTC

Market Talk

Dollar on Path to Snap Weekly Losing Streak -- Market Talk

DJ

Read

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

195.79% upside

12 Months Forecast

Average 103.88 USD  195.79%

High 135 USD

Low 30 USD

Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

7

Buy

1

Hold

1

Sell

Based on 9 analysts giving stock ratings to Nektar Therapeutics - Dist in the past 3 months.

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

JNJ

Johnson and Johnson

240

↑ +0.98%

UNH

UnitedHealth Group Inc

276.41

↑ +2.98%

TMO

Thermo Fisher Scientific Inc

542.03

↑ +0.18%

ABT

Abbott Laboratories

110.82

↑ +1.61%

ISRG

Intuitive Surgical Inc

487.26

↑ +2.36%
help-icon Live chat